Market Cap | ₹98,213Cr |
ROE | 18.89% |
P/E Ratio(TTM) | 21.48 |
EPS(TTM) | 45.44 |
P/B Ratio | 4.10 |
Dividend Yield | 1.13% |
Industry P/E | 33.86 |
Book Value | 238.05 |
Debt to Equity | 0.13 |
Face Value | 1 |
Parent Organisation | Zydus Lifesciences |
Managing Director | Dr. Sharvil Patel |
NSE Symbol | ZYDUSLIFE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 36.70 | ||
Cipla | NA (0.00%) | 22.45 | ||
Dr Reddy's Laboratories | NA (0.00%) | 18.40 | ||
Mankind Pharma | NA (0.00%) | 54.11 |